美股市場個股詳情
AUTL Autolus Therapeutics
- 3.260
- -0.060-1.81%
收盤價 12/02 16:00 (美東)
- 3.240
- -0.020-0.61%
盤後 19:54 (美東)
8.68億總市值-2672市盈率TTM
3.450最高價3.245最低價117.13萬股成交量3.390今開3.320昨收389.38萬成交額0.87%換手率虧損市盈率(靜)2.66億總股本7.45052周最高1.82市淨率4.38億流通值2.69052周最低--股息TTM1.34億流通股53.240歷史最高--股息率TTM6.18%振幅1.600歷史最低3.324平均價1股每手
關於Autolus Therapeutics公司
Autolus Therapeutics PLC 是一家生物製藥公司，致力於開發用於治療癌症的下一代程序化 T 細胞療法。 公司臨牀階段管線包括Obe-cel（obecabtagene autoleucel）、AUTO1/22、AUTO3、AUTO5、AUTO6、AUTO7和AUTO8。
公司介紹
公司代碼AUTL
公司名稱Autolus Therapeutics
上市日期2018/06/22
發行價格17.00
成立日期2018
CEODr. Christian Itin, PhD.
所屬市場納斯達克
員工數量471
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址The Mediaworks,191 Wood Lane,White City
城市倫敦
省份大倫敦
國家英國
郵編W12 7FP
電話44-20-3829-6230
董事高管
- 姓名
- 職務
- 年薪
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 192.11萬
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Dr. Edgar Braendle
- Senior Vice President and Chief Development Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- Martin Pule
- Senior Vice President and Chief Scientific Officer
- --
- Robert F. Dolski
- Senior Vice President, Chief Financial Officer
- --
- Alexander Swan
- Senior Vice President, Chief Human Resources Officer
- --
- Michael W. Bonney
- Chairman of the Board
- --
- Dr. Elisabeth Leiderman, M.D.
- Director
- 1.27萬
- Dr. Ravi Madduri Rao
- Director
- --
- Robert W. Azelby
- Director
- --
- John E. Berriman
- Independent Director
- 16.31萬
- Dr. Robert Iannone, M.D.
- Independent Director
- 13.49萬
- William D. Young
- Independent Director
- 17.58萬
- Dr. Martin Murphy, PhD
- Independent Director
- 15.83萬
- Cynthia M. Butitta
- Independent Director
- 16.46萬
- Linda C. Bain
- Independent Director
- 16.95萬
- Dr. Joseph Anderson, PhD.
- Independent Director
- 19.56萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據